NOV 11, 2015 03:00 PM PST

Proposed Rule for the Medicare Clinical Diagnostic Laboratory Test Payment System

  • President, Medical Technology Partners
      Jerry Stringham has worked as a reimbursement strategy consultant since the 1980s, when he began providing reimbursement consulting to diverse medical and pharmaceutical companies. Jerry holds a BS in mechanical engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School. He has been part of five medical device start-up organizations operating out of New England and has grown MTP's client list to over 140 clients. Jerry founded Medical Technology Partners in 1998 to fill the growing need for business-oriented reimbursement consulting. Jerry's experience in industry, including as a Principal in the health economics practice of a major CRO, brings expertise to new technology reimbursement challenges.


    Medical Technology Partner’s presentation is designed highlight what Medicare is proposing to do based on the Protecting Access to Medicare Act of April 1, 2014 with regard to clinical laboratory diagnostic tests in general and Laboratory Developed Tests in particular.

    This presentation’s learning objectives are to alert participants that there are:

    • Upcoming proposed changes in how Medicare proposes to pay for Clinical Diagnostic Laboratory Tests (CLDTs)
    • Key reimbursement proposals that could affect Laboratory Developed Tests (LDTs)
    • Easy ways to access the CMS source document and respond before  November 24, 2015

    Show Resources
    Loading Comments...